Bevacizumab (Avegra®) for the treatment of gynecological cancers: joint experience of several centers

• Glavni autori: A. G. Kedrova (Autor), S. Е. Krasilnikov (Autor), D. S. Ogay (Autor), Т. A. Maksimenko (Autor), V. I. Voznesenskiy (Autor), А. I. Berishvili (Autor), Т. A. Greyan (Autor)
• Format: Knjiga
• Izdano: ABV-press, 2021-03-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Tumors of the female reproductive system are among the five most common cancers in women worldwide. Up to 60 % of these patients require chemotherapy to reduce the risk of recurrence. Currently, an additional treatment option is available for patients with advanced cancers of the female reproductive...